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Abstract Homeobox containing genes are a family of transcription factors regulating normal
development and controlling primary cellular processes (cell identity, cell division and differ-
entiation) recently enriched by the discovery of their interaction with miRNAs and ncRNAs.
Class I human homeobox genes (HOX genes) are characterized by a unique genomic network
organization: four compact chromosomal loci where 39 sequence corresponding genes can
be aligned with each other in 13 anteroeposterior paralogous groups. The cardiovascular
system is the first mesoderm organ-system to be generated during embryonic development;
subsequently it generates the blood and lymphatic vascular systems. Cardiovascular remodel-
ling is involved through homeobox gene regulation and deregulation in adult physiology
(menstrual cycle and wound healing) and pathology (atherosclerosis, arterial restenosis,
tumour angiogenesis and lymphangiogenesis). Understanding the role played by homeobox
genes in endothelial and smooth muscle cell phenotype determination will be crucial in iden-
tifying the molecular processes involved in vascular cell differentiation, as well as to support
future therapeutic strategies. We report here on the current knowledge of the role played by
homeobox genes in normal and abnormal vasculogenesis and postulate a common molecular
mechanism accounting for the involvement of homeobox genes in the regulation of the nuclear
export of specific transcripts potentially capable of generating endothelial phenotype modifi-
cation involved in new vessel formation.
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Introduction
The cardiovascular system represents the first organ system
to be generated during embryonic development. Heman-
gioblasts, the pluripotent mesodermal stem cells, generate
blood islands, the peripheral part of which differentiate
into endothelial cells (EC) responsible for giving rise to de
novo vessel formation (vasculogenesis) [1]. The blood flow
remodels this early network of capillaries (angiogenesis) [2]
to stabilize the developing vessels through the recruitment
of vascular smooth muscle cells (VSMC). In parallel,
lymphatic unipotent EC, originated from the cardinal vein,
generate the lymph sacs that give rise to lymphatic vessels
[3]. These processes are consequent to proliferation,
differentiation and migration events which contribute to
the correct determination of the cardiovascular system.
Remodelling of the vascular system is realized during
embryonic development as well as in adult life and is con-
nected to physiological processes such as wound healing
and the menstrual cycle, as well as to disease states.
Pathological remodelling includes: (i) atherosclerosis where
VSMC migrate from the media to the intima progressively
occluding, through their proliferation, the arterial lumen
and generating hypoxia or even anoxia in downstream
tissues [4]; (ii) postangioplasty restenosis with neointimal
lesion formation has been recently reported to require
ERK1/2 down-regulation [5] and aberrant mir-21 micro-RNA
expression [6]. It is worth noting that the propensity to
thrombotic occlusion and atherosclerosis is different
between blood vessel types used for coronary bypass, cor-
responding to the gene expression profile of the VSMC in the
vessel type used [7]. Furthermore vascular remodelling
plays a critical role in tumour angiogenesis where
neoplastic cells produce pro-angiogenic factors such as
VEGF and l’FGF, responsible for stimulating the growth of
new blood vessels from EC cells with an immature pheno-
type [8]. This process will supply tumour growth through
diffusion of oxygen and nutrients.
In spite of the well documented role played by growth
factors and cytokines in the activation of receptors and
signalling pathways in both EC and VSMC, far less is known
about the function of the downstream transcription factors
activated by these signalling pathways to regulate tissue-
specific gene expression and growth and/or differentiation
of these cell types. Transcription factors represent
common targets which are regulated by the interaction of
multiple signalling pathways and regulate, in turn, tran-
scription of specific gene programmes that are crucial to
perform every cell function. They belong to several gene
families (winged helix, forkhead, high mobility group
proteins, homeobox, zinc fingers) among which homeobox
genes play a special role.
Homeobox genes are transcription factors that act
during normal development [9] and contain the homeobox,
a 183-bp DNA sequence coding for a 61-amino acid domain
defined as the homeodomain (HD). Different HD types or
classes may be identified through sequence similarities
within the homeodomain [10], each characterising
a homeobox gene family. Among these, the HD of the
homeotic gene of Drosophila Antennapedia (Antp) defines
a consensus sequence referred to as class I HD or Hox genes
[11]. In mice (Hox genes) and humans (HOX genes) there are
39 genes organized into four Hox loci, each localised on
a different chromosome (HOX A at 7p15.3, HOX B at
17p21.3, HOX C at 12q13.3 and HOX D at 2q31) [12] and
containing from 9 to 11 genes (Fig. 1). On the basis of
sequence similarity and position on the locus, correspond-
ing genes in the four clusters can be aligned with each other
into 13 paralogous groups [13]. During mammalian devel-
opment, Hox gene expression controls the identity of
various regions along the body axis according to the rules of
temporal and spatial co-linearity, with 30 Hox genes (reti-
noic acid responsive) expressed early in development and
controlling anterior regions, followed by progressively more
50 genes (FGF responsive) expressed later and controlling
more posterior regions [14]. The HOX gene network, the
most repeat-poor regions of the human genome [15], is also
expressed in normal adult human organs [16]. Homeobox
and Hox genes appear to regulate normal development,
phenotype cell identity [17,18] cell differentiation [19,20]
and control primary cellular processes, as proven by the
description of congenital [21], somatic [22], metabolic [23]
and neoplastic alterations [24,25] involving these genes. In
addition to their role as transcriptional regulators, new
Figure 1 Schematic representation of the HOX gene network (see the text for details).
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crucial functions have recently been ascribed to HOX genes
and homeoproteins mostly related to their interaction with
miRNAs and ncRNAs to guarantee transcription and trans-
lation of specific RNA transcripts [26,27].
Homeobox and HOX gene expression and deregulation of
the cardiovascular and lymphatic systems have been
reported since the nineties [28]. The increasing identifica-
tion of multiple physiological roles makes these genes ideal
candidates for unravelling the processes involved in cell
differentiation and vascular remodelling during normal
development, and whose alteration is associated with
pathology (Fig. 2). We review here the current knowledge
on HOX and Homeobox gene involvement during normal and
abnormal vasculogenesis.
Hox genes
An initial report has identified Hox A5, Hox A11, Hox B1, Hox
B7 and Hox C9 as able to distinguish, through their expres-
sion, foetal from adult human smooth muscle cells, thereby
modulating vasculature functions [29]. Subsequently,
paralogous group 3 HOX genes have been involved with the
regulation of the angiogenic phenotype: HOX D3 is abun-
dantly expressed in active proliferating EC forming tubes in
vitro and its expression is induced by basic fibroblast growth
factor (bFGF) [30]. HOX D3 overexpression further generates
haemangiomas in vivo. Constitutive HOX B3 expression
increases capillary morphogenesis without generating hae-
mangiomas, whereas anti-HOX B3 anti-sense inhibits capil-
lary morphogenesis [31]. In Hox A3/ knockout mice, the
arteries are shortened or absent, cardiogenesis is impaired
and neural crest precursors of the carotid artery initially
migrate properly but subsequently have a decreased
proliferation rate [32]. Taken together, these observations
suggest overlapping and complementary roles performed by
paralogous genesHox A3, Hox B3 andHox D3 in angiogenesis.
Recently, resulting phenotype of a truncating muta-
tion in HOX A1 has been reported [33] manifesting
vascular malformations of the internal carotid arteries
and cardiac outflow, besides mental retardation, autism
spectrum disorder, facial weakness and hypoventilation.
Increased Hox A5 expression is able to block angiogen-
esis in vivo and cell migration in vitro [34]. Hox A5 is
further active in quiescent EC and becomes silent after
EC activation by angiogenic stimuli. Interaction
between Hox A5 and vascular endothelial growth factor
receptor-2 (VEGFR-2) could account for the anti-angio-
genic affect [35].
HOX A9 has been involved with endothelial stem cell
determination. Hox A9 overexpression increases pro-
angiogenic EphB4 gene expression [36]. Hox A9 null mice
display a decreased response to angiogenic stimuli and
a low number of EC precursors. Hox A9 is able to bind to
endothelial nitric oxide synthase (eNOS) and VEGFR-2
promoters [37]. HOX A9 acts as a proinflammatory factor by
mediating cytokine induction of E-selectin [38] and is down-
regulated by NF-kB [39]. Thus, Hox A9 appears as a regu-
lator of angiogenesis.
Hox A13 is involved in extra embryonic vascularization,
since in Hox A13/ mice the EC layer of umbilical arteries
improperly form resulting in embryonic lethality. Hox A13
interacts with EphA7 and EphA4 in EC as the expression of
both Ephrin receptors is decreased in the umbilical arteries
of Hox A13 knockout mice [40].
Figure 2 Homeobox and Hox genes in normal and abnormal vasculogenesis. Normal vasculogenesis along embryonic development
is described at the top. The bottom represents tumour angiogenesis during adulthood. Inside the coloured boxes the homeobox and
Hox genes and the stage of their involvement in these processes are reported. The genes are indicated in red or blue when acting as
proangiogenesis or anti-angiogenic, respectively.
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Human umbilical vein endothelial cells (HUVEC) express
8 out of 10 HOX B locus genes suggesting their involvement
in the generation of new blood vessels [41]. HOX B2 induces
dose-dependent inhibition of in vitro HUVEC proliferation
[42]. Hox B5 transactivate the promoter of flk1 (VEGFR),
the earliest marker of endothelial precursors. Hox B5 mRNA
colocalises with flk1 expression in differentiating embryoid
bodies (HBE) and activates the cell-intrinsic events that
regulate the differentiation of angioblasts and mature
endothelial cells from their mesoderm-derived precursors
[43]. Hox B7 is able to transactivate pro-angiogenic factors
such as bFGF, VEGF, CXCL1, IL-8, Angiopoietin-2 and MMP-9
[44]. HOX B7 mRNA further appears to be highly expressed
in human atherosclerotic plaques than in normal human
arterial media [45]. Finally, testing the expression of the
whole HOX gene network, Chung et al. reported the up
regulation of HOX A7 and HOX B3 and the down-regulation
of HOX A3 and HOX B13 during endothelial cell differenti-
ation of human bone marrow-derived mesenchymal stem
cells [46].
Concerning the HOX C locus, the anti-sense targeting of
Hox C5 together with its paralogous genes Hox A5 and Hox
B5 causes the appearance of an additional pharyngeal arch
containing a novel and completely independent aortic arch
artery with normal cardiac outflow. Thus, abnormal aortic
arch patterning does not necessarily lead to cardiac mal-
formations [47]. HOX C9 is actively expressed both in
human smooth muscle cells and the cardiovascular system
during embryogenesis [29].
Hox D3, besides the involvement of the whole paralo-
gous group 3 HOX genes, appears to be one of the HOX
genes most involved with angiogenesis. In response to
wounding, Hox D3 expression increases in EC inducing the
production of collagen A1 and b3 integrin to improve wound
repair [48]. Ectopic Hox D3 expression in the mouse brain
induces increased levels of angiogenesis and cerebral blood
flow [49]. Basic FGF increases in EC and Hox D3 expression
which up-regulates the production of avb3 integrin and
urokinase-type plasminogen activator (uPA) necessary for
EC adhesion, migration and invasion [30]. Hox D3 is also
able to increase transcription of integrin avb1 in EC [50].
Hox D10 appears to be active in resting EC and displays
an anti-angiogenic effect blocking angiogenesis and
migration both in the endothelium [51] as well as in human
breast cancer cells, probably through down-regulation of a3
integrin expression [52].
Hex (Hhex)
The orphan homeobox gene Hex (Haematopoietically
expressed homeobox) also termed PRH (Proline Rich
Homeodomain) acts as both a transcriptional repressor and
activator, and is located on the human chromosome 10 [53].
Hex mRNA and protein are expressed in the developing
extra embryonic mesodermal blood islands (where vascular
and haematopoietic stem cells are located) immediately
after VEGFR-2. Hex is thus required for the initial phases of
endothelial differentiation and all along haematopoietic
differentiation. Hex is also active in VSMC inducing genes
such as plasminogen activator inhibitor 1 (PAI-1), nitric
oxide synthase 2A (iNOS), platelet-derived growth factor
alpha (PDGF-a), VEGFR-1 and VEGFR-2 [54]. Hex
homozygous disruption induces embryonic death in mice at
mid gestation due to severe defects in forebrain, thyroid
and liver development [55] as well as in B-cell develop-
ment, vasculogenesis and cardiac morphogenesis [56]. Hex
regulate the promoter of Naþ taurocholate cotransporting
polypeptide (ntcp), acts as a transcriptional repressor of
the liver, haematopoietic and HUVEC cells and, interacting
with GATA transcription factors, reduces the expression of
VEGFR-1 and VEGFR-2 in differentiated EC. It has recently
been reported that during liver development transition of
the hepatic endoderm to a pseudostratified epithelium is
dependent upon the activity of Hex to regulate ‘‘inter-
kinetic nuclear migration’’ during cell division [57]. Only
recently a direct in vivo Hex target has been identified as
the endothelial cell-specific molecule 1 (ESM-1) or endocan
[58]. ESM-1 protein is primarily expressed in the vascular
endothelial cells of the lung, kidney and gut and is induced
by VEGF and up-regulated in the endothelial lining of
tumour microvessels. A strong correlation has been repor-
ted between ESM-1 expression and the degree of tumour
vascularity [59]. Hex inhibits EC vessel formation in vitro
through the limitation of VEGFR-2 expression and Hex/
EC display a growth advantage over wild type cells [60].
Although the role of Hex in EC and VSMC differentiation as
well as in vasculogenesis and angiogenesis appears to be
crucial, it is clearly more complex than suspected. We will
postulate at the end a common mechanism accounting for
a potential unifying role of HOX and Hex genes in vasculo-
genesis and angiogenesis.
Prox1
Prox1 starts to be expressed in the primitive lymph sacs
originating from endothelial budding of the cardinal vein to
give rise to the lymphatic system. Prox1, homologous to the
gene prospero of Drosophila, has been connected to the
development of the lymphatic system. Prox1/ mouse
embryos do not develop a lymphatic system but undergo
normal vasculogenesis and angiogenesis. Other tissues such
as the eye lens, central nervous system and liver are
compromised leading to embryonic lethality [3]. Prox1
expression in vascular EC induce proliferation (prox1
up-regulate cyclin E1 and E2 expression) as well as
expression of lymphatic genes such as VEGFR-3 and des-
moplakin I/II [61] and repression of vascular EC genes such
as STAT 6 and neuropilin I. A direct target of Prox1 is
fibroblast growth factor receptor 3 (FGFR3), required for
lymphatic EC proliferation. The Drosophila prospero gene is
involved in asymmetric cell divisions generating different
cell types during embryonic development [62]. Thus, Prox1
plays a role in the control of cell proliferation and in the
regulation of the developing lymphatic system.
Gax
Gax (growth arrest-specific homeobox) is a Mesenchyme
homeobox 2 (Meox2) transcription factor involved in
vascular phenotype determination. It is expressed, during
embryonic development, in several tissues and organs
including all the three muscle lineages and brain [63]. In
adult life, Gax expression concerns the cardiovascular
tissues, smooth muscle cells of arteries and lung and
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mesengial cells of the kidney. In VSMC, Gax is down-regu-
lated by mitogenic stimuli (PDGF, angiotensin II) and up-
regulated by growth arrest signals (serum deprivation). Gax
negatively regulates the cell cycle in VSMC by up-regulating
p21, a cyclin dependent kinase 2 (cdk2) inhibitor [64].
Recently miR-130a has been reported as able to regulate
the angiogenic phenotype of vascular endothelial cells
modulating the expression of GAX and HOX A5 [65]. Gax is
also able to control VSMC migration toward chemotactic
growth factors suppressing the b3 and b5 subunit of integrin
avb3 and avb5 [66]. Thus, Gax inhibits the angiogenic
phenotype, probably through an NF-KappaB-dependent
mechanism [67].
Prx
Upregulation of the paired-related homeobox genes Prx1
and Prx2 is detectable in rat pulmonary arteries after
pulmonary hypertension, and induces transactivation of
Tenascin-C which promotes proliferation of cultured VSMC
[68]. Prx1 knockout mice manifest malformations of the
aorta and the ductus arteriosus; Prx1/Prx2 double knockout
mice display more severe malformations supporting an
additive and compensatory role for these two genes [69].
Prx1 and Prx2 regulate embryonic VSCM proliferation as
well as VSCM de-differentiation occurring in vascular
diseases.
eIF4E, nuclear export and angiogenesis
Eucaryotic translation initiation factor (eIF4E) is actively
expressed in human cancers, promoting tumour growth and
angiogenesis. Elevated eIF4E levels selectively increase
translation of growth factors in malignancy (e.g., VEGF,
cyclin D1) and represent potential anticancer therapeutic
targets [70]. Recently eIF4E has been found to migrate into
the nucleus generating multi-protein nuclear structures
(eIF4E nuclear bodies) [71]. eIF4E nuclear bodies promote
the selective transport of specific mRNAs, such as cyclin D1
and ornitine decarboxylase (ODC), from nucleus to cyto-
plasm [72]. In mammalian cells eIF4E nuclear bodies are
inhibited by Hex and PML (promyelocytic leukaemia
protein), whereas they are modulated by the interaction
with HOX A9 through a binding site on the HOX A9 homeo-
protein corresponding to the sequence YVDSFLL [73]. The
property of HOX A9 to act on RNA export is independent of
its role as a transcriptional regulator. Several homeo-
proteins display consensus sequences to act as eIF4E
binding proteins (4EBPs) corresponding to YXXXXLF (where
X is any amino acid and F is any hydrophobic amino acid).
It has recently been reported that PML is a critical
regulator of angiogenesis in ischaemia and tumours through
the inhibition of hypoxia-inducible factor 1 alpha (HIF-1a)
translation [74]. We have previously described the role of
the homeobox gene Hex and HOX A9 in vasculogenesis and
angiogenesis. Thus all the homeoproteins involved in the
interaction with eIF4E nuclear bodies in the process of
nuclear export of selected transcripts appear to be involved
with vasculogenesis and angiogenesis. Alteration in the
regulation of nuclear export may well be an upstream event
generating endothelial phenotype modification involved in
new vessel formation. The reported statistical analysis
describing the consensus sequence YXXXXLF as present in
200 out of 800 homeoproteins suggests an increasingly
important role for the homeobox genes in normal and
abnormal vasculogenesis [73].
Conclusions
Despite homeobox genes being identified 30 years ago, it
still appears difficult to define their functions. This is not
only due to the lack of effector gene identification but also
to the complex and not completely elucidated role that
homeobox genes play in physiology and pathology.
From a genetic viewpoint, the Hox gene network as
a whole represents a complex system responsible for real-
ising specific gene programmes, selected through the cell
memory gene mechanisms, to establish phenotype cell
identity and cellecell interactions and to regulate tissue and
organ formation whose spatioetemporal organization fits
the formal arrangement of the network (Fig. 1). At
a molecular level, the gene programmes are realized by the
Hox genes acting as transcription factors through the coor-
dinate regulation of downstream gene batteries. The bio-
logical functions performed by the effector genes span from
cell cycle to apoptosis, from the interaction with growth
factors to the production of adhesion molecules and to the
involvement with cell signalling. Obviously all this cannot be
due to a single Hox gene but to the coordinate combination
of the 39 genes of the network and of their interactions with
isolated and divergent homeobox genes in the genome.
These processes are consequent to the interactions between
Hox genes and miRNAs and ncRNAs, crucial players in the
regulation of gene expression localised, in some cases, even
inside the Hox network.
The Hox genes as transcriptional regulators, although
crucially involved with gene programme realization, are
limited by the generation of mRNAs with an uncertain fate
due the complexity of the subsequent processes such as
nuclear export and protein synthesis.
In order to secure the correct realization of the gene
programmes selected as transcription factors, the Hox
proteins (homeoproteins) perform the recently identified
different role of interaction with nuclear bodies. Nuclear
bodies are protein clumps interacting inside the cell
nucleus with specific mRNA sequences (see Hox and eIF4E)
involved with RNA maturation and nuclear export. These
processes are characterized by the interaction between
homeoproteins and nucleoporins, proteins of the nuclear
pore able to allow mRNAs to cross the nuclear membrane to
reach cytoplasm for protein synthesis. Alteration of these
processes is leukaemogenic due to the generation of
chimerical proteins between several HOX genes and the
nucleoporin NUP98 [75]. The interaction between eIF4E
nuclear bodies and homeoproteins represents a further
potential level of involvement of homeoprotein with
translation. Thus, from a molecular viewpoint, Hox genes
play a crucial role in the regulation of transcription, nuclear
export and potentially in the initial steps of protein
synthesis.
The general properties of Hox and homeobox genes we
have described are perfectly superimposable to the role of
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these genes along vasculogenesis. The expression of the
whole Hox gene network during EC differentiation concerns
the majority of the 39 genes in the network and varies in
different body districts according to the spatio temporal
rules. The role of homeobox and Hox genes acting as
a transcriptional regulator, as well as a selector of angio-
genic programmes, is supported by several observations
mostly related to the interaction with growth factors (Hex
and VEGFR-1, Hex and VEGFR-2, Hox A5 and VEGFR-2, Hox
B5 and flk1) and with integrins (Hox D3 and avb1, Hox D10
and a3).
The involvement of miRNA in the transcription of
angiogenic programmes is proven by the recent discovery
of the regulation of angiogenesis through miR-130a that
down regulates anti-angiogenic homeobox genes GAX and
HOX A5 [65].
The interaction with nuclear bodies is supported by
the possibility of homeoproteins to interact with eIF4E in
the generation of eIF4E nuclear bodies (this represents
the function performed by 68% of eIF4E proteins produced
inside a cell). These processes are strictly connected to
cellecycle and angiogenesis. Hyper expression of eIF4E is
related to VEGF hyper expression and induces an increase
in vasculogenesis.
The interaction between Hox and nucleoporins involved
in the nuclear export play an important role with respect to
vasculogenesis: it has recently been shown that the fusion
protein between Hox A9 and NUP98 increases the expres-
sion of PIM-1, a gene able to induce EC migration and vessel
reconstruction [76].
Finally, from a practical viewpoint, using small inter-
fering RNA (siRNA) to inhibit genes in vitro and in vivo has
improved studies on the mechanism of action of angiogenic
genes. The capability of using RNA in vivo to validate
angiogenesis factors as drug targets is uniquely important
because its pathological impact can only be characterized
accurately in animal disease models. siRNA protect mice
from fulminant hepatitis [77], viral infection, sepsis and
tumour growth. With the emergence of clinically viable
delivery vehicles, anti-angiogenesis RNAi agents appear to
have a promising and unprecedented role for the treatment
of many serious human diseases that result from excessive
angiogenesis. Using this systemic delivery of siRNA target-
ing VEGF pathway factors at sites of neovascularization,
anti-angiogenic efficacy has been achieved in a neuroblas-
toma tumour model [78].
HOX and siRNA interference have only recently, in the
last few years, been coupled following the discovery of
siRNA functionality in mammalian cells. Deregulation of
HOX A9 by RNA interference decreases cell migration and
tube formation of endothelial human cells, suggesting
that HOX A9 plays a role in endothelial cell migration and
may exert its function by regulating the expression of
EphB4 [36].
A deeper understanding of the homeobox gene involve-
ment in the regulation of vascular remodelling and angio-
genesis will certainly improve the development of
therapeutic strategies to contrast tumour angiogenesis,
atherosclerosis, restenosis after angioplasty, wound healing
and lymphoedema, taking into account that paralogous
group Hox genes (such as the group 3 Hox genes in the
cardiovascular system) often interact in performing
additive functions to generate the redundancy of the Hox
system.
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